Intellia Therapeutics, Inc. — DEFA14A Filings
7 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Intellia Therapeutics, Inc. (NTLA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Intellia Therapeutics, Inc. has filed 7 DEFA14A documents with the SEC since 2015. To view all SEC filings by Intellia Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0000950170-25-061058 | Apr 30, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-24-049909 | Apr 29, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-23-160821 | Jun 5, 2023 | — |
| DEFA14A | DEFA14A | 0000950170-23-016273 | May 1, 2023 | — |
| DEFA14A | DEFA14A | 0000950170-22-006884 | May 2, 2022 | — |
| DEFA14A | DEFA14A | 0001564590-21-021426 | Apr 28, 2021 | — |
| DEFA14A | DEFA14A | 0001564590-20-018497 | Apr 24, 2020 | — |